FIELD: medicine.
SUBSTANCE: invention relates to a method for reducing erythrocyte aggregation. Method of reducing erythrocyte aggregation involves intravenous administration to a subject in need thereof, a solution containing sodium aminodihydrophthalazinedione and a solvent, selected from a group consisting of water for injections and solution of 0.9 wt.% sodium chloride in water, with the following ratio of ingredients mg/ml: sodium aminodihydrophthalazinedione—0.25–20.0; solvent—balance.
EFFECT: method described above has a better safety profile and enables to reduce erythrocyte aggregation after intravenous administration of sodium aminodihydrophthalazinedione solution.
1 cl, 2 dwg, 4 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION IN FORM OF SOLUTION FOR INJECTIONS OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE AND PYRIDOXIN, METHOD OF ITS OBTAINING AND METHOD OF TREATMENT | 2008 |
|
RU2383331C1 |
SOLUTION FOR INTRAVENOUS AND INTRAMUSCULAR INTRODUCTION BASED ON ETHYL-METHYL-HYDROXYPYRIDINE SUCCINATE AND METHOD OF PRODUCTION THEREOF | 2015 |
|
RU2605825C1 |
METHOD FOR TREATMENT OF RECURRENT VULVOVAGINAL CANDIDIASIS | 2016 |
|
RU2642666C1 |
METHOD FOR TREATING CHRONIC INFLAMMATORY DISEASES | 2002 |
|
RU2216328C1 |
PREPARATION FOR PREVENTING AND TREATING INFLAMMATORY PROCESSES IN ANIMALS | 2019 |
|
RU2725773C1 |
METHOD OF TREATING CHRONIC CYSTITIS | 2008 |
|
RU2386440C1 |
RADIOPROTECTIVE, RADIOMITIGATORY AND RADIOSENSITIZING AGENT BASED ON SODIUM SALT OF AMINODIHYDROPHTHALAZINEDIONE SODIUM (DRUG TAMERON) AND OTHER ALKALI AND ALKALINE EARTH METAL SALTS OF AMINODIHYDROPHTHALAZINEDIONE | 2022 |
|
RU2804886C1 |
PHARMACEUTICAL COMPOSITION OF ANTI-CD20 ANTIBODY AND USE THEREOF | 2022 |
|
RU2824627C2 |
METHOD FOR TREATING HEMORRHAGES INTO INTERNAL MEDIA AND MEMBRANES OF AN EYE ACCOMPANIED WITH BLOOD PLATELETS HYPERAGGREGATION | 1998 |
|
RU2161020C2 |
PHARMACEUTICAL INJECTION TILORONE-BASED COMPOSITION FOR TREATMENT OF DISEASES WITH IMMUNODEFICIENCY SIGNS | 2007 |
|
RU2364390C1 |
Authors
Dates
2024-06-17—Published
2023-04-28—Filed